Roivant Sciences Ltd. · NASDAQ:ROIV

Sukhatme Mayukh reported 7 trades in Roivant Sciences Ltd. shares (Form 4)

Traded Nov 10 to Nov 12, 2026 · Filed Nov 12, 2026

From Nov 10 to Nov 12, 2026, Sukhatme Mayukh (Director, President & CIO) reported 7 trades in Roivant Sciences Ltd. shares at an average US$41.02 for US$6.79M, leaving 18,396,703 shares. Filed Nov 12, 2026 (Form 4).

Shares
165,444 shares
Price
US$41.02 average (US$40.36 to US$42.01)
Value
US$6.79M
Holding after
18,396,703 shares
Trading plan
No
Role
Director, President & CIO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 10, 2026Common SharesOther26,152US$40.4318,537,732Direct
Nov 10, 2026Common SharesOther32,882US$41.1318,504,850Direct
Nov 11, 2026Common SharesOther32,672US$41.6318,472,178Direct
Nov 11, 2026Common SharesOther20,533US$42.0118,451,645Direct
Nov 12, 2026Common SharesOther44,723US$40.3618,406,922Direct
Nov 12, 2026Common SharesOther8,482US$41.1318,398,440Direct
Nov 12, 2026Common SharesShares withheld for tax1,737US$41.8518,396,703Direct

Source

Download original · View original at SEC

Related